Table 4 Clinical profiles and response to treatment in our patients treated with sclerotherapy
From: Cervicofacial lymphatic malformations: diagnosis and management
Case number | Age of onset | Sex | Time to 1st consultation | Location | Lesion size (mm) | Sclerosing agent | Number of injections | Follow-up | Response to treatment |
|---|---|---|---|---|---|---|---|---|---|
8 | 12 years | Female | 2 months | Right submaxillary and floor of the mouth | 50 × 35 30 × 21 | Aetoxisclerol 2% | 1 | 15 months | Complete resolution |
9 | 7 years | Male | 5 years | Left parotid | 62 × 55 | Hypertonic saline with Aetoxisclerol 2% | 1 | 1 year | Complete resolution |
10 | 13 years | Female | 3 months | Left parotid | 23 × 21 | Hypertonic saline with Aetoxisclerol 2% | 2 | 9 months | Complete resolution |
11 | 45 years | Female | 2 months | Right parotid | 53 × 42 | Absolute alcohol | 2 | 5 years | Significant regression |
12 | At birth | Female | 12 months | Right laterocervical region | 39 × 19 | Hypertonic saline with Aetoxisclerol 2% | 1 | Lost to follow-up | Lost to follow-up |